Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Applied Dna Scns (NQ: APDN )

7.930 USD +0.290 (+3.80%)
Official Closing Price Updated: 7:55 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Applied Dna Scns

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Thinking about buying stock in Greenlane Holdings, vTv Therapeutics, Evolus Inc, Applied DNA Sciences, or Mogo Inc?
InvestorsObserver issues critical PriceWatch Alerts for GNLN, VTVT, EOLS, APDN, and MOGO. 
From PR Newswire
Applied DNA and Evvivax Initiate Phase I of Clinical Trial to Evaluate LinearDNA™ COVID-19 Vaccine Candidate for Feline Veterinary Market
If the veterinary vaccine candidate demonstrates effectiveness, the two companies intend to apply to USDA to enable commercial vet sales under APHIS. 
From Business Wire News Releases
Applied DNA Granted U.S. Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authentication
Newly granted patent has applicability in the DNA tagging of pharmaceutical, nutraceutical and personal care excipients. 
From Business Wire News Releases
Thinking about buying stock in Vascular Biogenics, Oncolytics Biotech, Protalix Biotherapeutics, AMC Entertainment, or Applied DNA Sciences?
InvestorsObserver issues critical PriceWatch Alerts for VBLT, ONCY, PLX, AMC, and APDN. 
From PR Newswire
Applied DNA to Provide Back-To-Campus COVID-19 Surveillance Testing to LIM College
NYC-based LIM College joins other education institutions relying on Applied DNA's safeCircle service to ensure a safe learning environment. 
From Business Wire News Releases
Applied DNA Reports First Fiscal Quarter 2021 Revenues at Upper End of Guided Range
Reports First Fiscal Quarter 2021 Revenues at Upper End of Guided Range 
From Business Wire News Releases
Applied DNA and Cytocheck Detect First Instance of SARS-CoV-2 B.1.1.7 Variant in Kansas
Linea(TM) COVID-19 Assay Kit utilized in genomic surveillance mode detects first instance of SARS-CoV-2 B.1.1.7 (UK) variant in Kansas. 
From Business Wire News Releases
Applied DNA Schedules Fiscal 2021 First Quarter Financial Results Conference Call and Webcast for Thursday, February 11, 2021
Applied DNA Sciences, Inc. (NASDAQ: APDN) announced today that it will report fiscal 2021 first quarter financial results after market close on Thursday, February 11, 2021. The Company’s management... 
From Business Wire News Releases
Applied DNA Achieves Program Milestone in Development of Linear DNA Veterinary COVID-19 Vaccine
"Our veterinary vaccine program is a cost- and time-efficient path to commercializing our COVID-19 vaccine development work." 
From Business Wire News Releases
InvestorNewsBreaks – Applied DNA Sciences Inc. (NASDAQ: APDN) Has Closed Registered Direct Offering Resulting in $15M
From InvestorBrandNetwork
Applied DNA and TruTrace Technologies™ Unveil Complete Cannabis Product Validation and Authentication Solution
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the signing of a definitive agreement with TruTrace... 
From Business Wire News Releases
Applied DNA Promotes Judith Murrah to Chief Operating Officer
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the promotion of Chief Information Officer Judith Murrah... 
From Business Wire News Releases
Thinking about buying stock in Gevo, Applied DNA Sciences, Surface Oncology, Aldeyra Therapeutics, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for GEVO, APDN, SURF, ALDX, and BNGO. 
From PR Newswire
Applied DNA Linea™ COVID-19 Assay Kit Demonstrates Effectiveness with Detection of Multiple SARS-CoV-2 Variants During Recent Surveillance Testing
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its Linea™ COVID-19 Assay Kit (the “Assay Kit”)... 
From Business Wire News Releases
Thinking about buying stock in VBI Vaccines, Senseonics Holdings, Aemetis, Applied DNA Sciences, or Aphria?
InvestorsObserver issues critical PriceWatch Alerts for VBIV, SENS, AMTX, APDN, and APHA. 
From PR Newswire
Applied DNA Provides Business Update on COVID-19 Diagnostics and Testing
Applied DNA Sciences, Inc. (NASDAQ:APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its safeCircle™ pooled surveillance testing service... 
From Business Wire News Releases
Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the closing of its previously announced registered direct... 
From Business Wire News Releases
Applied DNA Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it has entered into a securities purchase agreement... 
From Business Wire News Releases
U.S. FDA Lists Applied DNA’s Linea™ COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7)
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that the U.S. Food and Drug Administration (FDA)... 
From Business Wire News Releases
Applied DNA to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that Dr. James A. Hayward, president and CEO, will participate... 
From Business Wire News Releases
Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it expects revenues for the first... 
From Business Wire News Releases
Applied DNA Partners with CLEARED4 on Pooled COVID-19 Surveillance Testing Program
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that its wholly-owned subsidiary,... 
From Business Wire News Releases
Applied DNA Reports 2020 Year End and Fiscal Fourth Quarter Financial Results
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced consolidated financial results for the... 
From Business Wire News Releases
Applied DNA Awarded Pooled Surveillance Testing Contract Valued at Up to $2.0 Million from Suffolk County (N.Y.) Government
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its wholly-owned subsidiary,... 
From Business Wire News Releases
Compliance with New York State Winter COVID-19 Plan Drives Demand for Applied DNA’s Pooled Surveillance Testing Program
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that its Applied DNA Clinical Laboratories,... 
From Business Wire News Releases
Applied DNA Schedules Fiscal 2020 Fourth Quarter Financial Results Conference Call for Thursday, December 17, 2020 at 4:30 PM EST
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it will release financial results... 
From Business Wire News Releases
Nutrition21 Transitions to Applied DNA’s CertainT® Platform to Secure IP-protected Portfolio of Dietary Supplement Ingredients
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the expansion of commercial activities... 
From Business Wire News Releases
Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that its wholly-owned subsidiary, Applied DNA... 
From Business Wire News Releases
Applied DNA, EvviVax, and GVS Receive Regulatory Approval to Conduct Veterinary Clinical Trial for Linear COVID-19 Vaccine Candidate
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, EvviVax, S.R.L. (“EvviVax”), a spin-off of Takis Biotech... 
From Business Wire News Releases
Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that it is scheduled to participate virtually... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.